GSK

GSK is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Their products are used by millions of people around the world, helping them to do more, feel better and live longer. They have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Their commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. By achieving th... is, they will be able to grow their business and provide benefits to patients, consumers, society, their employees and shareholders. With their headquarters in the UK, they have a wide geographical reach. They have offices in more than 115 countries, major research centres in the UK, USA, Spain, Belgium and China and an extensive manufacturing network with 87 sites globally. Research is vitally important to the success of their business, and they spent just under £4 billion in 2012 in their search to develop new medicines, vaccines and innovating consumer products.
GSK
Industry:
Consumer Health Care Pharmaceutical Venture Capital
Founded:
2000-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network COVID-19 QUIC New Relic Thing Schema SEO_H2 SEO_H1
Similar Organizations
Aperture Venture Partners
Aperture Venture Partners is a New York-based venture capital focused on medical device, pharmaceutical, healthcare, and diagnostic sectors.
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Brook Venture Partners
Brook Venture Partners is a Massachusetts-based company that provides capital to expansion-stage healthcare IT and tech-enabled services.
Duo Xi Yue Mu Ying Yue Zi Hui Suo
Duo Xi Yue Mu Ying Yue Zi Hui Suo provides scientific, healthy and cost-effective one-stop confinement services for confinement moms.
Echo Health Ventures
Echo Health Ventures is a venture capital firm that focuses on investing in health care companies.
Home Delivery Incontinent Supplies
Home Delivery Incontinent Supplies is specialized in providing quality care to those who experience loss of bladder control.
Lerer Hippeau
Lerer Hippeau is an early-stage venture capital fund founded and operated in New York City.
Maveron
Maveron is a consumer-only venture capital firm that empower consumers to live on their terms.
Mommi
Mommi is a consumer products company focused on enhancing women’s lives, with an emphasis on the years surrounding pregnancy.
Therma Bright
THERMA BRIGHT is a progressive business in medical device development, focused on delivering affordable medical devices to customers.
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Advisors List
Board_member
2021-04-01
Current Employees Featured
Jerome Andries SVP finance R&D @ GSK
SVP finance R&D
2017-08-01
Satish Maram Global Director ECommerce @ GSK
Global Director ECommerce
2020-07-01
Mehdi El Gueddari Principal Software Engineer @ GSK
Principal Software Engineer
Steven Harrison Senior Planning Engineer @ GSK
Senior Planning Engineer
Emma Walmsley CEO @ GSK
CEO
2017-01-01
Amy Labroo Director, Digital Marketing & OmniChannel @ GSK
Director, Digital Marketing & OmniChannel
2017-10-01
Jim Kennedy Product Manager / Tribe Leader NGS Vaccines @ GSK
Product Manager / Tribe Leader NGS Vaccines
2021-05-01
Patrick Vallance President, Pharmaceuticals R&D @ GSK
President, Pharmaceuticals R&D
Radu Rapiteanu Scientific Leader, Functional Genomics @ GSK
Scientific Leader, Functional Genomics
2020-11-01
Philip Thomson Senior Vice President, Global Communications @ GSK
Senior Vice President, Global Communications
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2018-10-08 | Sitryx Therapeutics | GSK investment in Series A - Sitryx Therapeutics | 30 M USD |
2015-06-15 | Calporta Therapeutics | GSK investment in Series A - Calporta Therapeutics | 10 M USD |
2015-06-01 | Cadherx Therapeutics | GSK investment in Series A - Cadherx Therapeutics | 10 M USD |
2012-10-25 | Thrasos | GSK investment in Series C - Thrasos | 35 M USD |
2011-07-08 | Springleaf Therapeutics | GSK investment in Series B - Springleaf Therapeutics | 19.05 M USD |
2010-07-30 | Anacor Pharmaceutical | GSK investment in Venture Round - Anacor Pharmaceutical | 15 M USD |
2009-02-06 | diaDexus | GSK investment in Post-IPO Equity - diaDexus | 9.2 M USD |
2009-01-06 | Anacor Pharmaceutical | GSK investment in Series E - Anacor Pharmaceutical | 50 M USD |
2008-04-30 | Concert Pharmaceuticals | GSK investment in Series C - Concert Pharmaceuticals | 37 M USD |
2008-02-13 | CalciMedica | GSK investment in Series B - CalciMedica | 5.5 M USD |
Newest Events participated

More informations about "GSK"
Board of directors and leadership team - GSK
Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act statement …See details»
Home | GSK Canada
GlaxoSmithKline Inc. 100 Milverton Drive, Suite 800, Mississauga, ON L5R 4H1 > GSK Modern Slavery Act Statement 2023 (PDF - 154.2KB) GSK websitesSee details»
Purpose, strategy and culture - GSK
Culture at GSK is something we all own. It powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive. Our culture of being ambitious for patients, …See details»
GSK plc - Wikipedia
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British-American multinational pharmaceutical and biotechnology company with headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. GSK is the tenth largest pharmaceutical company and No. 294 on the 2022 Fortune Global 500, …See details»
Company | GSK Canada
Trademarks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. GlaxoSmithKline Inc. 100 Milverton Drive, Suite 800, Mississauga, ON L5R 4H1 > GSK Modern Slavery …See details»
Canada leadership team - GSK
Trademarks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. GlaxoSmithKline Inc. 100 Milverton Drive, Suite 800, Mississauga, ON L5R 4H1 > GSK Modern Slavery …See details»
GSK - The Org
GSK. 297 followers ‌ GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. ...See details»
Welcome to GSK Organization
GSK Organization We have a fleet of over 8 years experienced skilled staff, well operational facilities and the capability on the Management all these features help you achieve your Goals in your Business through our Services. Whether …See details»
Organization structure of Gsk | PPT - SlideShare
May 5, 2016 GlaxoSmithKline is a leading pharmaceutical company with a 15% market share in Pakistan. The document outlines GSK's organization chart and HR policies. It describes GSK's HR department structure and key functions …See details»
Inclusion | GSK US
Building a high-performing, inclusive organization. Over recent years, we’ve delivered a step-change in performance and we believe in the power of an inclusive culture and differing …See details»
Home | GSK US
The homepage of the GSK USA website. March 25 2025 Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and …See details»
Org Chart GSK - The Official Board
Organizational Chart of GSK. GSK www.gsk.com. has 197 executives and 24 subsidiaries +44 208 047 5000; Add an executive. GSK (GSK) News . Anything missing? We search for you. …See details»
Home | GSK
Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United …See details»
Gsk organizational presentaion | PPT - SlideShare
May 21, 2015 GSK aims to grow a diversified global business, deliver more innovative products, and simplify its operating model as it is a large, complex organization with over 96,000 …See details»
Company | GSK US
Getting ahead of disease is one of the greatest, most inspiring challenges there is on the planet. By pursuing this purpose together, we have the scale and expertise to positively impact the …See details»
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley ...
3 days ago For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in this revolution. ... We had to rewire the …See details»
GSK gears up for depemokimab debut with phase 3 data dump
Mar 3, 2025 GSK presented the data at the 2025 joint congress of the American Academy of Allergy, Asthma and Immunology and the World Allergy Organization. The results were also …See details»
GSK taking an innovative approach to improving health care in …
Nov 15, 2024 In 2023, GSK invested over $18.4 million into 53 active clinical trials across Canada involving 3,334 active subjects, part of its overall investments of over $121 million in …See details»
Purpose, strategy and culture | GSK Canada
GlaxoSmithKline Inc. 100 Milverton Drive, Suite 800, Mississauga, ON L5R 4H1 > GSK Modern Slavery Act Statement 2023 (PDF - 154.2KB) GSK websitesSee details»
GSK’s Kim Branson on driving innovation with AI and machine …
Mar 4, 2025 In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&D, hosts Navraj Nagra and Alex Devereson speak to Kim Branson, senior vice president and …See details»